ET
WVE icon

Entropy Technologies’s Wave Life Sciences WVE Stock Holding History

Entropy Technologies’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$467K Buy
80,449
+52,101
+184% +$345K 0.02% 679
2026
Q1 		$206K Sell
28,348
-2,265
-7% -$29.5K 0.01% 799
2025
Q4 		$520K Buy
+30,613
New +$311K 0.03% 549

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Entropy Technologies's WVE Position: Q2 2026 in Review

Entropy Technologies increased its Wave Life Sciences (WVE) stake by 184% in Q2 2026, buying an estimated $345K and bringing the position to 80,449 shares worth $467K. The position accounts for 0.02% of the portfolio, ranked #679.

Entropy Technologies first reported a position in WVE in Q4 2025 and has held it in 3 quarters since. The position peaked at $520K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Entropy Technologies held 80,449 shares of Wave Life Sciences worth $467K as of Q2 2026.
  • Entropy Technologies bought 52,101 Wave Life Sciences shares in Q2 2026, an estimated $345K.
  • Wave Life Sciences made up 0.02% of Entropy Technologies's portfolio in Q2 2026, its #679 holding.
  • Entropy Technologies first reported a position in Wave Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • Entropy Technologies's Wave Life Sciences position peaked at $520K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.